Pharmacy
February 8, 2021
Doctor Sentenced for Role in Unlawful Distribution of Opioids
An Ohio physician was sentenced to two years in prison today for his role in illegally distributing opioids.
January 15, 2021
Federal Court Restrains Toledo Pharmacy and Two Pharmacists From Dispensing Opioids or Other Controlled Substances
A federal court in Ohio issued a temporary restraining order enjoining a Toledo, Ohio, pharmacy and two of its pharmacists from dispensing opioids and other controlled substances, the Department of Justice announced today.
January 3, 2021
Former Walmart Pharmacists Say Company Ignored Red Flags As Opioid Sales Boomed
When Ashwani Sheoran showed up for early morning shifts at pharmacies in rural Michigan wearing his white Walmart smock, he often found customers waiting, desperate for bottles of pain pills.
December 7, 2020
Another Opioid Bellwether Delayed For COVID-19
Law360 (December 7, 2020, 5:32 PM EST) -- An Ohio federal judge on Friday moved the May 2021 trial date for a bellwether case brought by two Ohio counties against pharmacies in the opioid multidistrict litigation to October 2021 due to concerns over the coronavirus pandemic.
October 31, 2020
COVID-19 postpones next phase of Summit County federal opioid trial
The COVID-19 pandemic has postponed the next phase of a federal trial involving Summit and Cuyahoga counties that focuses on the pharmacy industry's role in the opioid epidemic.
October 26, 2020
Walmart sues U.S. over its responsibility in opioid crisis
Walmart is suing the U.S. government as a pre-emptive strike in an anticipated legal battle over the retailer's responsibility in the opioid-abuse crisis.
October 13, 2020
Ohio judges delay two major opioid trials against pharmacies, distributors
CLEVELAND, Ohio – Judges in Ohio have postponed two major opioid trials scheduled to begin within weeks.
October 14, 2020
Ohio judges postpone 2 major trials blaming pharmacies, distributors for opioid epidemic
Judges in Ohio have postponed two major opioid trials involving lawsuits that seek to penalize drugmakers and distributors